Company intelligence
Exelixis
About Exelixis
Every Exelixis employee is united in an ambitious cause: to transform science into new treatments that give cancer patients and their families hope for the future. In this pursuit, we know our employees are our most valuable asset. As a diverse, growing team, everyone at Exelixis plays a role in advancing our mission through our innovative drug discovery, development and commercialization efforts. We take pride in our shared purpose, knowing the magnitude of our impact expands with every medicine we create and every form of cancer tumor type we treat. After operating in the challenging biotech sector for nearly three decades, we've evolved into a multi-platform cancer company with a proven track record of resiliency in the face of adversity. The success of our flagship commercial product set us up on our journey to discover and develop next-generation cancer treatments, driven by our relentless pursuit of results for the patients we serve. Cancer is our cause. Make it yours, too. Please see our Community Guidelines: bit.ly/4iBzJU0 For more information about Exelixis, please visit www.exelixis.com, follow @ExelixisInc on Twitter or like Exelixis, Inc. on Facebook.
Verified activity
Signals from Exelixis
3 published signals
Presence & Recognition
Exelixis hosted the Voices of Strength event hosted by the Employee Experience Resource Group, EXELerate Hope, where colleagues Jim Wilburn, Joan Gratton, Robert Ziegler, and the entire Exelixis community shared their personal stories.
Reported by Exelixis
People
Exelixis is growing its leadership team and looking to hire a Vice President for GMP Quality Assurance.
Reported by Khalid Shah Ph.D.
Research & Knowledge
Exelixis published a press release detailing the latest update on patent litigation involving its flagship therapy.
Reported by Exelixis